XML 59 R40.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions - Additional Information (Detail) (USD $)
In Millions, except Per Share data, unless otherwise specified
3 Months Ended 12 Months Ended 1 Months Ended 3 Months Ended 1 Months Ended 1 Months Ended
Dec. 31, 2011
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
May 20, 2010
Bard Sendirian Berhad
Apr. 12, 2010
FlowCardia, Inc.
Apr. 12, 2010
FlowCardia, Inc.
Core Technologies
Dec. 31, 2011
Clearstream Technologies
Dec. 31, 2011
Clearstream Technologies
Core Technologies
Other Intangible Assets
Oct. 19, 2012
Neomend, Inc.
Oct. 19, 2012
Neomend, Inc.
Core Technologies
Dec. 31, 2012
Lutonix, Inc.
Dec. 31, 2011
Lutonix, Inc.
Dec. 16, 2011
Lutonix, Inc.
Dec. 16, 2011
Lutonix, Inc.
In-Process Research And Development
Dec. 16, 2011
Lutonix, Inc.
Core Technologies
Nov. 10, 2011
Medivance, Inc.
Nov. 10, 2011
Medivance, Inc.
Core Technologies
Nov. 10, 2011
Medivance, Inc.
Customer Relationships
Jul. 06, 2010
SenoRX, Inc.
Jul. 06, 2010
SenoRX, Inc.
Core Technologies
Business Acquisition [Line Items]                                          
Business acquisition purchase price         $ 25.9 $ 80.1   $ 69.1   $ 133.7       $ 298.0     $ 255.5     $ 213.5  
Business acquisition, contingent consideration                   25.0   72.0   100.0              
Business acquisition, contingent consideration payment due date                   2016                      
Purchase price allocation, recognition of customer relationships and core technologies             46.4   29.1   62.8         33.4   75.9 88.7   95.1
Purchase price allocation at fair value, recognition of deferred tax assets           18.1   3.3   27.0       24.7     25.0     42.3  
Purchase price allocation at fair value, recognition of deferred tax liabilities           19.3   3.8   36.0       59.5     63.3     44.0  
Purchase price allocation at fair value, recognition of other net liabilities                   1.9                      
Purchase price allocation at fair value, recognition of indefinite-lived intangible asset           4.7       29.4         131.5         12.8  
Risk-adjusted discount rate                   24.00%   20.00%                  
Purchase price allocation at fair value, goodwill           27.2   29.5   52.4       166.3     112.2     83.8  
Estimated useful lives, years           11 years   10 years     15 years         12 years   14 years 13 years 10 years  
Acquisition related transaction costs 3.8   3.8         2.6   1.3       1.4     1.7     3.2  
Business acquisition, purchase consideration cash payment                           228.0              
Fair value of contingent consideration                           70.0              
Purchase price allocation at fair value, recognition of other net assets           3.0               1.6     17.0        
Probability of payment of contingent consideration                       75.00% 75.00%                
Integration costs recorded to other (income) expense before tax 4.1 2.1 4.4 9.3       2.0                 1.8        
Integration costs recorded to other (income) expense after tax               1.8                 1.1        
Assets acquired in acquisition               11.0                       23.5  
Business acquisition purchase price per share                                       $ 11.00  
Acquisition costs, termination of agreements                                       6.9  
Acquisition costs, termination of agreements, after tax                                       4.2  
Excess of cash paid over the carrying amount of the noncontrolling interest         $ 13.2                                
Business acquisition percentage of common shares acquired         15.00%